Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...

New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...

Speech blurs together unless you know the language; scientists found the brain signal that separates the words ...

Abstract: Deep learning (DL)-based automatic modulation classification (AMC) exhibits substantial potential to improve signal processing accuracy and efficiency in intelligent communication systems.